An observational study assessing the effectiveness and safety of single pill combination of amlodipine/valsartan/hydrochlorothiazide in Egyptian patients with hypertension uncontrolled on any dual therapy.

Trial Profile

An observational study assessing the effectiveness and safety of single pill combination of amlodipine/valsartan/hydrochlorothiazide in Egyptian patients with hypertension uncontrolled on any dual therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Dec 2016

At a glance

  • Drugs Amlodipine/valsartan/hydrochlorothiazide (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Dec 2016 New trial record
    • 13 Jun 2016 Primary endpoint (mean change in systolic and diastolic blood pressure) has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top